![]() |
|
|

* The University of Wisconsin School of Pharmacy, Madison, WI 53705-2222; and
The University of Wisconsin School of Veterinary Medicine, Madison, WI 53706-1102
3To whom correspondence should be addressed. E-mail: blneudeck{at}pharmacy.wisc.edu.
Augmentation of the normal flora of the gastrointestinal tract with probiotic bacteria is currently under investigation as a therapeutic tool for several diseases. However, it is unknown whether probiotic bacteria such as Lactobacillus casei alter the expression and function of intestinal transport proteins such as hPEPT1. The effects of 24 and 48 h incubation of Caco-2 cells with 108/L L. casei on the hPEPT1-mediated uptake rate of 20 µmol/L [3H]glycylsarcosine were examined. Dipeptide uptake did not differ from the control at 24 h (15.9 ± 2.4 vs. 11.5 ± 1.4 cm · s1 · mg protein1); however, a significant increase in uptake occurred after 48 h of L. casei treatment (23.7 ± 1.5 vs. 12.0 ± 1.9 cm · s1 · mg protein1; P = 0.005). hPEPT1 involvement was confirmed in experiments using excess substrate. Increased uptake of [3H]glycylsarcosine appeared to be the result of the direct interaction of the bacteria with Caco-2 cells because conditioned medium had no effect on dipeptide uptake. hPEPT1 mRNA levels did not differ at any time point. These results show that prolonged incubation of Caco-2 cells leads to increased hPEPT1 activity and that this occurs by a mechanism distinct from increased gene expression.
KEY WORDS: hPEPT1 Lactobacillus casei Caco-2 cells glycylsarcosine
This article has been cited by other articles:
![]() |
A-P Bai and Q Ouyang Probiotics and inflammatory bowel diseases. Postgrad. Med. J., June 1, 2006; 82(968): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boullata Natural Health Product Interactions with Medication Nutr Clin Pract, February 1, 2005; 20(1): 33 - 51. [Abstract] [Full Text] [PDF] |
||||